Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors
So far, the studies demonstrate that Lynparza has activity in cancer patients with and without inherited BRCA mutations.
writer, health care advocate, physician
So far, the studies demonstrate that Lynparza has activity in cancer patients with and without inherited BRCA mutations.
Anne Parker’s perspective on cancer care – as a family member, patient and advocate – spans over 50 years.
What’s great about this piece, and what’s wrong about it, is that it comes from an individual woman.